Barry Investment Advisors’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
Other funds holding AZN
BTCPP
AIM
PAS
MBI
GI
CTA
B
PNC
MCM
Barry Investment Advisors's AZN Position: Q3 2026 in Review
Barry Investment Advisors held its AstraZeneca (AZN) position steady in Q3 2026 at 1,980 shares worth $320K. The position accounts for 0.06% of the portfolio, ranked #72.
Barry Investment Advisors first reported a position in AZN in Q1 2021 and has held it in 23 quarters since. The position peaked at $390K in Q1 2026. 137 funds tracked by Wall St. Rank hold AZN as of Q3 2026.
- Barry Investment Advisors held 1,980 shares of AstraZeneca worth $320K as of Q3 2026.
- Barry Investment Advisors left its AstraZeneca share count unchanged in Q3 2026.
- AstraZeneca made up 0.06% of Barry Investment Advisors's portfolio in Q3 2026, its #72 holding.
- Barry Investment Advisors first reported a position in AstraZeneca in Q1 2021 and has held it in 23 quarters since.
- Barry Investment Advisors's AstraZeneca position peaked at $390K in Q1 2026.
- 137 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2026.
Based on Barry Investment Advisors's 13F filing for Q3 2026, filed 14 Oct 2026.